CLSK Stock Slips As Losses Deepen And Insiders Signal Sales

CleanSpark Inc. stocks have been trading down by -8.92 percent amid bearish sentiment over bitcoin price volatility and mining profitability.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading CLSK

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways Traders Need To Know

Fiscal Q3 for CleanSpark came in weak, with EPS at -$0.89 versus a -$0.48 Wall Street estimate, flagging sharply worse-than-expected losses.
Multiple Form 144 filings show insiders or affiliates of CLSK signaling plans to sell restricted or control securities under SEC Rule 144.
The repeated insider sale intentions add a supply overhang for CLSK just days after the disappointing earnings report.
Chart action in CLSK shows fading bounces and lower highs as traders digest the earnings miss and looming insider selling.

Live Update At 12:32:13 EDT: On Friday, August 28, 2026 CleanSpark Inc. stock [NASDAQ: CLSK] is trending down by -8.92%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

CLSK is trading like a name under pressure. Over the past couple of weeks, CleanSpark has slid from a high near $14.65 down toward the low-$12s, with a recent close around $11.80. That’s a clear downtrend on the daily chart, with each bounce getting sold and lower highs stacking up.

On the intraday tape, CLSK shows a steady bleed. Pre-market levels near $12.80 failed, and the stock trended down through midday toward the $11.70s. That kind of grind lower, with no sharp panic flush yet, often tells traders that sellers are still in control and dip buyers are timid.

More Breaking News

Fundamentals back up the cautious read. CleanSpark’s fiscal Q3 EPS of -$0.89 represents a sizable loss, and it badly missed the -$0.48 consensus. Revenue is growing, but profitability metrics for CLSK are deeply negative, with heavy operating losses and negative margins. The company carries meaningful debt but also has solid liquidity, including more than $200M in cash and a strong current ratio. For short-term traders, though, the key takeaway is simple: CLSK remains a high-volatility, loss-making name, and the trend right now leans down.

Why Traders Are Watching CLSK Now

Traders are glued to CLSK because the story just shifted from growth excitement to damage control. The earnings miss on 2026/06/30 set the tone: CleanSpark printed EPS of -$0.89 for fiscal Q3, a much deeper loss than the -$0.48 analysts expected. When a company misses by that margin, the market reads it as either costs getting away from management or revenue not scaling fast enough to cover the build-out.

For CLSK, the income statement shows heavy operating expenses and a negative gross profit for the quarter. That tells traders the core business is still far from break-even. At the same time, depreciation and amortization are huge, which is common for capital-intensive, growth-stage operations but still painful when the bottom line is so red.

Then, right after those results, a string of Form 144 filings hit. One Form 144 showed an insider or affiliate of CleanSpark planning to sell a block of restricted or control stock under SEC Rule 144. Additional Form 144 notices from other insiders or restricted holders signaled more planned sales, and one filing pointed to a major holder preparing to unload shares.

For CLSK traders, that combination matters. A big earnings miss can be waved off if insiders are buying or holding tight. Here, they are signaling intentions to sell. Even though Form 144s are only notices — not proof the sales already happened — they tell the market that multiple CLSK insiders are at least open to reducing exposure. That adds a perceived supply overhang on the tape, especially with CLSK already sliding off recent highs.

Conclusion

For active traders, CLSK is now a textbook cautionary setup. CleanSpark is growing revenue but posted a harsh fiscal Q3 loss of -$0.89 per share, missing the -$0.48 consensus by a wide gap. The balance sheet for CLSK shows meaningful cash and working capital, but profitability is nowhere in sight right now, with margins buried deep in the red and free cash flow sharply negative.

Layer on top the wave of Form 144 filings, and the narrative sharpens. Multiple insiders, affiliates, and even a major holder of CLSK have filed notices to sell restricted or control securities under Rule 144. Those are intentions, not guarantees, but traders pay attention when key holders step toward the exit right after weak numbers. That potential selling pressure can cap rallies and keep CLSK pinned or drifting lower.

In this kind of tape, disciplined traders treat CLSK as a trading vehicle, not a hope-and-pray hold. The chart is trending down, liquidity is decent, and headlines are clearly bearish — a mix that rewards fast reactions and strict risk control. That starts before the market even opens: as Tim Bohen, lead trainer with StocksToTrade says, “Preparation is half the trade. By the time the bell rings, my decisions are nearly made.” As Tim Sykes loves to say, “Cut losses quickly; small losses are manageable, big ones never are.” For anyone trading CLSK, that mindset is not optional — it’s survival.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!